Albert Pinhasov

Johnson & Johnson (United States)

Papers

2

Total Citations

50

H-Index

2

About

Albert Pinhasov is a leading researcher in functional genomics and high-throughput screening technologies, with a focus on accelerating drug discovery and target validation. His major contributions include pioneering siRNA-based methods for functional target validation, as demonstrated in his highly cited 2004 paper (33 citations), which established efficient approaches for identifying and validating therapeutic targets. He also advanced gene expression analysis by developing an automated high-throughput TaqMan RT-PCR method, enabling quantitative mRNA profiling at unprecedented scale. This work, detailed in his 2004 publication (17 citations), integrated the Allegro (Zymark) system for sample tracking and liquid handling, addressing the growing demand for rapid, reliable gene expression data in pharmaceutical research. Pinhasov’s innovations have significantly enhanced the efficiency of early-stage drug development, providing researchers with robust tools for target discovery and validation. His work bridges molecular biology and automation, making him a notable figure in the field of high-throughput screening and functional genomics.

Research Focus

Key Achievements

2
H-Index
2
Papers
50
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput siRNA-Based Functional Target Validation
33 citations · 2004
📈 Most Prolific Year: 2004 (2 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago